IGF1 and Alzheimer disease: In the present study, we observed increased expression of the proinflammatory mediators, TNF-α, IL-1β and iNOS, and decreased expression of the neurotrophic factors, IGF-1, GDNF and BDNF, in the hippocampus of AD model rats.